Insider trade

Globus Medical (GMED)Director sold ~$170K

Ann D Rhoads, Director at Globus Medical, sold ~$170K of Globus Medical shares.

~$170K
Approx. value · 2,000 sh @ $85.00
15K
Holds after · shares reported
Traded
Nov 10, 2025
Filed
Nov 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 15, 2025InsiderDirector sold ~$585K of GMED shares in the open market
  2. Oct 16, 2025Federal contract · $25K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $25K obligated to date
  3. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  4. Nov 7, 2025InsiderDirector sold ~$648K of GMED shares in the open market
  5. Nov 10, 2025 · this disclosureInsiderDirector sold ~$170K of GMED shares in the open market

What came next

  1. Nov 11, 2025InsiderDirector sold ~$2.11M of GMED shares in the open market
  2. Nov 12, 2025InsiderDirector sold ~$2.15M of GMED shares in the open market
  3. Nov 25, 2025InsiderOfficer sold ~$675K of GMED shares in the open market
  4. Dec 12, 2025InsiderDirector sold ~$355K of GMED shares in the open market
  5. Jan 7, 2026Company filing · Form 8-K · ResultsReported its results
  6. Jan 8, 2026Insider · 2 peopleInsiders: 2 sales (~$566K)
  7. Jan 13, 2026Federal contract · $42K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $42K obligated to date
  8. Jan 15, 2026Federal contract · $61K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $61K obligated to date
  9. Jan 22, 2026Federal contract · $27K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $27K obligated to date
  10. Jan 28, 2026Federal contract · $31K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $31K obligated to date
  11. Feb 12, 2026InsiderOfficer sold ~$877K of GMED shares in the open market
  12. Feb 20, 2026Federal contract · $64K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $64K obligated to date
  13. Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
  14. Feb 25, 2026Insider · Their largest sale since 2019Officer sold ~$1.89M of GMED shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Globus Medical

For Globus Medical, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 12 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GMED page.

Other recent filings by Ann D Rhoads, Director

The full history of Ann D Rhoads, Director is on the profile page.

How this filing works

Other disclosures at Globus Medical

Everything OQRO holds on this company is on its GMED page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data